<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="https://sms.carm.es/ricsmur/handle/123456789/17704">
<title>02.07.01. Investigación y comunicación científica</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/17704</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://sms.carm.es/ricsmur/handle/123456789/25869"/>
<rdf:li rdf:resource="https://sms.carm.es/ricsmur/handle/123456789/25865"/>
<rdf:li rdf:resource="https://sms.carm.es/ricsmur/handle/123456789/25864"/>
<rdf:li rdf:resource="https://sms.carm.es/ricsmur/handle/123456789/25827"/>
</rdf:Seq>
</items>
<dc:date>2026-04-17T09:23:00Z</dc:date>
</channel>
<item rdf:about="https://sms.carm.es/ricsmur/handle/123456789/25869">
<title>Mortalidad y fracaso renal agudo en pacientes con ventilación no invasiva</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/25869</link>
<description>Mortalidad y fracaso renal agudo en pacientes con ventilación no invasiva
Cinesi-Gómez, César; Vigil-Velis, Martín; Antonio-González, Marina-M; Serrano-Navarro, Juana-M; Rico-Lledo, María-José
</description>
<dc:date>2019-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://sms.carm.es/ricsmur/handle/123456789/25865">
<title>Comparación de distintas estrategias para la predicción de muerte a corto plazo en el paciente anciano infectado</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/25865</link>
<description>Comparación de distintas estrategias para la predicción de muerte a corto plazo en el paciente anciano infectado
Cecilia-Yáñez, María; Salido-Mota, Manuel; Fuentes-Ferrer, Manuel; Julián-Jimenez, Agustín; Piñera-Salmerón, Pascual; Llopis, Ferran; Gamazo-del-Rio, Julio; Martínez-Ortiz-de-Zarate, Mikel; Estella, Ángel; Martín-Sanchez, Francisco-Javier; González-del-Castillo, Juan; Herrero-Puente, Pablo; Rubio-Díaz, Rafael; Moya-Olmeda, Diana; López-Izquierdo, Raul; Sánchez-Nicolás, José-Andrés; Álvarez-Hurtado, Ángel-Aurelio; del-Pozo-Vegas, Carlos; Gallardo-Bautista, José; Candel, Francisco-Javier; Cobanera-Echebarría, Borja; Román, Francisco; Llorens, Pere; Perales, Ramón; Oñate, Javier; Mora-Ordóñez, Begoña; Fragero, Eva; Ortega, Mar; Burillo, Guillermo; Gómez-Hernández, Carolina; Arranz, María-Jesús; Juarez, Ricardo; Ferreras-Amez, José-María; Muro, Eva; Pérez-Ordoño, Luis; García-Criado, Jorge; von-Wernitz, Andrés; del-Arco, Carmen; Marchena-Yglesias, Pablo-Javier; Ruiz, Francisco; García-Castrillo, Luis; Alonso, Héctor; Salido, Manuel; Rodríguez-Miranda, Belén; Ruiz-Grinspan, Martín; Guardiola-Tey, Josep-María; Herrera-Mateo, Sergio; Mateo-Roca, Miriam; Ezponda, Francisco-José; Díez, Elena; Gracia-García, Francisco; Huarte, Itziar; Gayoso-Martín, Sara; Cubillo-Moreno, María; Juárez-de-Sosa, Silvia; de-la-Chica, Ana; Ferre-Losa, Carles; del-Río-Navarro, Rigoberto; Iglesias-Vela, Marta; Maestro-Gilmartin, Luis-Miguel; Avellaneda-Martinez, Carlos; Álvarez-Rodríguez, Virginia; Fernández-Rodríguez, Manuel; Guiu-Martí, Alexandra-María; Salmeron-Beliz, Octavio-J; Flores-Quesada, Silvia; Troiano-Ungerer, Osvaldo; Cano-Rodríguez, Tania; Lapuerta-Irigoyen, Luis; Andonegui, Carmen; Cortés, Nieves; Muñoz-Gamito, Gema; Valle-Borrego, Beatriz; Arranz-Betegon, María; Sierra-Moreno, Ángel; Chanovas-Borras, Manel-R; Urraca-Gamaury, Ainhoa; Cruzado-Quevedo, Jesús; Carpio-Munoz, Verónica; Marchante-Tejada, Cristobal; Menchaca, Bakarne; Modol-Deltell, Josep-María; Macías-López, Ángel; Lecinera, María-Ángeles; Sarra-Moreto, Salvador; Suero-Méndez, Coral; Pendón-Fernández, Salvador; Rodríguez, Raimundo; Cardenete-Aljama, Miguel-Ángel; Fernández-Rivas, Maite; Amador, Luis; Cobo-Muñoz, José-Eduardo; Carrasco, Elena; Rodríguez-Salazar, David; Núñez-Orantos, María-José; Rodríguez-Adrada, Esther
</description>
<dc:date>2019-04-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://sms.carm.es/ricsmur/handle/123456789/25864">
<title>Influencia de la protocolización del tratamiento inicial con corticoides en la estancia y costo de las neumonías adquiridas en la comunidad. Estudio prospectivo 2015</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/25864</link>
<description>Influencia de la protocolización del tratamiento inicial con corticoides en la estancia y costo de las neumonías adquiridas en la comunidad. Estudio prospectivo 2015
Gómez-Gómez, Joaquín; Gómez-Torres, Jorge-Luis; Hernández-Torres, Alicia; García-Cordoba, José-Antonio; Canteras-Jordana, Manuel
</description>
<dc:date>2017-10-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://sms.carm.es/ricsmur/handle/123456789/25827">
<title>Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)</title>
<link>https://sms.carm.es/ricsmur/handle/123456789/25827</link>
<description>Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023)
Berenguer, Juan; Fanciulli, Chiara; Arcos, María M; Vivancos, María J; Domingo, Pere; Hernando, Asunción; Barrado, Julia; Ryan, Pablo; Navarro, Jordi; Palacios, Rosario; Morano, Luis E; Iribarren, José A; Martínez, Rosa; Galindo, María J; de Los Santos, Ignacio; López-Cruz, Ian; Rivero, Antonio; Pérez-Latorre, Leire; Giner, Livia; Fariñas, María C; García, Coral; Montero-Alonso, Marta; Ferrero, Óscar L; Villoslada, Aroa; Soler-González, Josefa F; Sanz, José; Rodríguez, Sergio; Losa, Juan E; Bernal-Morell, Enrique; Veloso, Sergio; Pérez-Martínez, Laura; Mateos, Fernando; Arbonés, Laia; Franch, Raquel; Corps, Diana; Martín, Cristina; Alonso-García, Gerardo; Clavero-Olmos, Marta; Silvariño, Rafael; Teira, Ramón; Belinchón, Olga; de Miguel, Marta; Jarrín, Inmaculada; González-García, Juan
BACKGROUND: Hepatitis C virus (HCV) has significantly impacted people with human immunodeficiency virus (HIV). Harm reduction programs, changing transmission patterns, and direct-acting antivirals (DAAs) have profoundly altered HIV/HCV coinfection trends. This study evaluates HCV prevalence among people with HIV in Spain over 2 decades. METHODS: We conducted 9 cross-sectional studies (2002-2023) in 39-43 centers. Sampled individuals were randomly sampled from people with HIV actively followed up at these centers, with proportional allocation. Main outcomes included the prevalence of anti-HCV antibody and active HCV infection (HCV RNA--positive result). RESULTS: The reference population ranged from 31 800 to 47 006, with sample sizes of 1260-1867. HIV transmission patterns shifted from 2002 to 2023, with injection drug use decreasing from 55% to 21% and the proportion of men who have sex with men increasing from 17% to 46%. HCV seroprevalence fell from 60.8% to 27.4%, and active infection from 46.3% to 0.9%. In the DAA era (2015-2023), active HCV infection dropped by 100% in heterosexuals, 94% in people who inject drugs, and 71% in men who have sex with men. Treatment uptake increased from 23% in 2002 to 99% by 2023 with all-oral DAAs. The prevalence of cirrhosis among active HCV cases peaked at 23.1% in 2015 but fell to 0% by 2021. Among those achieving sustained virologic response, cirrhosis prevalence was 20.4% in 2023. CONCLUSIONS: HIV/HCV coinfection has drastically declined in Spain, with active HCV infection prevalence &lt;1% since 2021. DAAs were pivotal in this achievement. However, cirrhosis remains a concern among those with sustained virologic response. Ongoing surveillance and prevention efforts are essential to sustain these gains and address residual risks.
</description>
<dc:date>2026-03-17T00:00:00Z</dc:date>
</item>
</rdf:RDF>
